Although historically debated, recent literature supports RS as a distinct clinical entity, often associated with a positive speckled ANA pattern, anti-Ro/SSA, anti-La/SSB antibodies, and sometimes anti-Sm antibodies [6,9]. The gene discussed is CALR; the disease is X-linked retinoschisis.